Quick Answer
Ocean Biomedical, Inc. reported Diluted EPS of $0.34 per share (loss) for fiscal year 2024.
Ocean Biomedical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.34 | +92.2% |
| 2023 | -$4.35 | -487.8% |
| 2022 | -$0.74 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$0.09 | -118.8% | +55.0% |
| September 30, 2024 | -$0.20 | +62.3% | +68.3% |
| June 30, 2024 | -$0.63 | -46.5% | -231.2% |
| March 31, 2024 | $0.48 | +116.6% | +190.6% |
| September 30, 2023 | -$0.53 | -231.2% | -23.3% |
| June 30, 2023 | -$0.43 | -38.7% | +85.2% |
| March 31, 2023 | -$2.90 | — | -1712.5% |
| September 30, 2022 | -$0.16 | — | +48.4% |
- Ocean Biomedical, Inc. showed an increase of +92.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2024 period, Ocean Biomedical, Inc.’s diluted eps has grown by 54.1% (from $0.74 per share (loss) to $0.34 per share (loss)).
- The most recent figure is from Ocean Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: